Silo Pharma Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Silo Pharma stock has a target of $10, which predicts a 2,457.54% increase from the current stock price of 0.39.

Price Target: $10 (+2,457.54%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$10	$10	$10	$10
Change	+2457.5%	+2457.5%	+2457.5%	+2457.5%

Analyst Ratings

According to 1 stock analyst, the rating for Silo Pharma is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '23
Strong Buy	0
Buy	0
Hold	0
Sell	0
Strong Sell	0
Total	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yale Jen Laidlaw & Co.	Laidlaw & Co.	Strong Buy Initiates $10	Strong Buy	Initiates	$10	+2,457.54%	Aug 28, 2023

Financial Forecast

Revenue This Year

73.44K

from 72.10K

1.86%

from 72.10K

Revenue Next Year

n/a

from 73.44K

EPS This Year

-0.73

from -0.50

EPS Next Year

n/a

from -0.73

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	71.26K	72.10K	72.10K	72.10K	72.10K	73.44K
Revenue Growth	-	1.18%	-	-	-	1.86%
EPS	1.30	-1.71	-1.20	-1.19	-0.50	-0.73
EPS Growth	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026
High	75,600
Avg	73,440
Low	70,560

Revenue Growth

Revenue Growth	2026
High	4.9%
Avg	1.9%
Low	-2.1%

EPS Forecast

EPS	2026
High	-0.76
Avg	-0.73
Low	-0.71

EPS Growth

EPS Growth	2026
High	-
Avg	-
Low	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.